You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Medtronic
AstraZeneca
Boehringer Ingelheim
Harvard Business School

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Patent: 7,598,362

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,598,362
Title:Hepatitis C virus vaccine
Abstract: The present invention features Ad6 vectors and a nucleic acid encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region. The nucleic acid is particularly useful as a component of an adenovector or DNA plasmid vaccine providing a broad range of antigens for generating an HCV specific cell mediated immune (CMI) response against HCV.
Inventor(s): Emini; Emilio A. (Wayne, PA), Kaslow; David C. (Rancho Santa Fe, CA), Bett; Andrew J. (Lansdale, PA), Shiver; John W. (Chalfont, PA), Nicosia; Alfredo (Rome, IT), Lahm; Armin (Rome, IT), Luzzago; Alessandra (Rome, IT), Cortese; Riccardo (Rome, IT), Colloca; Stefano (Rome, IT)
Assignee: Merck & Co., Inc. (Rahway, NJ) Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A. (Rome, IT)
Application Number:10/492,178
Patent Claims:see list of patent claims

Details for Patent 7,598,362

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Merck & Co., Inc. (Rahway, NJ) Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A. (Rome, IT) 2021-10-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Merck & Co., Inc. (Rahway, NJ) Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A. (Rome, IT) 2021-10-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Merck & Co., Inc. (Rahway, NJ) Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A. (Rome, IT) 2021-10-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Merck
Express Scripts
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.